Menu
Search
|

Menu

Close
X

ICON PLC ICLR.OQ (NASDAQ Stock Exchange Global Select Market)

115.06 USD
+0.05 (+0.04%)
As of Feb 20
chart
Previous Close 115.01
Open 114.89
Volume 140,859
3m Avg Volume 106,730
Today’s High 118.43
Today’s Low 114.89
52 Week High 124.33
52 Week Low 76.50
Shares Outstanding (mil) 54.04
Market Capitalization (mil) 6,140.73
Forward P/E 23.06
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 16 analysts

KEY STATS

Revenue (mm, USD)
FY17
1,758
FY16
1,666
FY15
1,575
EPS (USD)
FY17
5.129
FY16
4.648
FY15
4.010
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
23.06
32.90
Price to Sales (TTM)
vs sector
3.57
5.77
Price to Book (MRQ)
vs sector
5.96
5.41
Price to Cash Flow (TTM)
vs sector
18.43
23.42
Total Debt to Equity (MRQ)
vs sector
33.87
16.52
LT Debt to Equity (MRQ)
vs sector
33.87
12.22
Return on Investment (TTM)
vs sector
20.24
14.43
Return on Equity (TTM)
vs sector
28.29
16.13

EXECUTIVE LEADERSHIP

Ciaran Murray
Chairman of the Board, Since 2017
Salary: $606,000.00
Bonus: $4,230,000.00
Steve Cutler
Chief Executive Officer, Director, Since 2017
Salary: --
Bonus: --
Brendan Brennan
Chief Financial Officer, Since 2012
Salary: $262,000.00
Bonus: $1,416,000.00
Diarmaid Cunningham
Executive Vice President, General Counsel, Secretary, Since 2014
Salary: --
Bonus: --
Hugh Brady
Non-Executive Director, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

South County Business Park, Dubl
DUBLIN     00000

Phone: +3531.2912000

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

SPONSORED STORIES